Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction.

about

Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction.

Item

http://www.wikidata.org/entity/Q37582213

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Conservative pharmacotherapy v ...... evation myocardial infarction.

@en

Conservative pharmacotherapy v ...... evation myocardial infarction.

@nl

type

Item

label

Conservative pharmacotherapy v ...... evation myocardial infarction.

@en

Conservative pharmacotherapy v ...... evation myocardial infarction.

@nl

prefLabel

Conservative pharmacotherapy v ...... evation myocardial infarction.

@en

Conservative pharmacotherapy v ...... evation myocardial infarction.

@nl

P1476

Conservative pharmacotherapy v ...... evation myocardial infarction.

@en

P2093

Bo Zhao

http://www.w3.org/2001/XMLSchema#string

Huiming Ye

http://www.w3.org/2001/XMLSchema#string

Jianjun Peng

http://www.w3.org/2001/XMLSchema#string

Licheng Lei

http://www.w3.org/2001/XMLSchema#string

Lihui Ren

http://www.w3.org/2001/XMLSchema#string

Zuoyan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Bivalirudin during primary PCI in acute myocardial infarction

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.

Clinical end points in coronary stent trials: a case for standardized definitions.

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

Complete versus culprit only revascularization in acute ST elevation myocardial infarction: a meta-analysis.

Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.

P304

4147-4153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2016.3895

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28105141

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

5228445

http://www.w3.org/2001/XMLSchema#string